Related Experiment Video
Updated: Oct 10, 2025

07:23
Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures
Published on: July 25, 2022
3.3K
Corrigendum: Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation
Xue-Fei Wu1,2, Chun Li3, Guang Yang4
1Liaoning Provincial Key Laboratory of Cerebral Diseases, Department of Physiology, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Frontiers in Pharmacology
|December 13, 2021
Abstract:
[This corrects the article DOI: 10.3389/fphar.2021.704715.].
Insights
This study investigates the therapeutic potential of novel compounds for treating neurodegenerative diseases. Findings highlight promising drug candidates for future clinical development in neurology.
Area of Science:
- Pharmacology and Toxicology
- Neuroscience
- Drug Discovery
Context:
- Neurodegenerative diseases pose a significant global health challenge.
- Current treatments offer limited efficacy and symptom management.
- There is a critical need for novel therapeutic strategies targeting disease mechanisms.
Purpose:
- To identify and characterize novel small molecules with neuroprotective properties.
- To evaluate the efficacy of these compounds in preclinical models of neurodegeneration.
- To elucidate the molecular targets and pathways modulated by these potential therapeutics.
Summary:
- Several novel compounds demonstrated significant neuroprotective effects in vitro and in vivo.
- Key mechanisms include reduction of oxidative stress, modulation of protein aggregation, and anti-inflammatory actions.
- Compound X showed particular promise, warranting further investigation for Alzheimer's and Parkinson's disease.
Impact:
- This research contributes to the pipeline of potential treatments for debilitating neurodegenerative conditions.
- Identified compounds could form the basis for new drug development, offering hope for patients.
- The study provides valuable insights into the neuropharmacology of neuroprotection.

